ProfileGDS4459 / ENSG00000035687
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 83% 78% 79% 83% 84% 83% 79% 80% 80% 81% 86% 81% 83% 87% 76% 82% 79% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.2983
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.778
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.1479
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.0783
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.5684
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.3683
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.1379
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.2280
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.2780
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.2781
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.7986
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.3381
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.4583
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.6487
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.9276
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.182
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.8679